Peering Into Accelerate Diagnostics's Recent Short Interest
Portfolio Pulse from Benzinga Insights
Accelerate Diagnostics (NYSE:AXDX) has seen a 26.07% decrease in short interest since its last report, with 448 thousand shares sold short, representing 2.58% of its float. The average time to cover these short positions is 24.74 days. While a decrease in short interest can indicate a more bullish sentiment, it does not necessarily predict a near-term price rise. Accelerate Diagnostics has a higher short interest than its peer group average of 1.48%.
January 31, 2024 | 5:15 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Accelerate Diagnostics's short interest has decreased, which may indicate a more bullish sentiment among investors. However, this does not assure an immediate increase in stock price.
A decrease in short interest typically suggests that investors are less bearish on the stock, which could lead to a potential increase in price. However, the impact is not certain and depends on broader market conditions and company performance.
CONFIDENCE 75
IMPORTANCE 60
RELEVANCE 100